Revolution Medicines, Inc. Warrant

RVMDW

Biotechnology · Healthcare

Exchange

NASDAQ Global Select

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Revolution Medicines is a biotechnology company focused on developing cancer drugs. It targets a family of proteins called RAS, which are mutated in roughly 25% of all human cancers, making them one of the most common drivers of tumor growth. The company is working on several experimental medicines designed to block these proteins and stop cancer cells from growing.

The ticker RVMDW represents a warrant, which is a financial instrument that gives holders the right to buy shares of Revolution Medicines stock at a set price in the future — it is not the common stock itself. Revolution Medicines earns no product revenue yet, as its drugs are still in clinical trials. The company operates primarily in the United States and funds its research through capital raises and partnerships. Its main competitive edge is its deep focus on RAS-targeted therapies, a historically difficult area where few drugs have succeeded. The biggest risk is clinical failure, since none of its drugs have received regulatory approval yet.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-133.6% YoY

YoY Growth Rate

Earnings declining

Insider Activity

10.6%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~16 months

$4.0B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

-52.6%

Weak — -52.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.19

Conservative — low debt load (0.19)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial